Alan Crane

Investor type:
Locations:

Social media:

Available after registration.

Past investments

  • KSQ Therapeutics
  • Noema Pharma
  • Quartet Health
  • Notarize
  • Cardurion Pharmaceuticals
  • NetRate Systems
  • Recurly
  • Armorblox
  • Amagma Therapeutics
  • FOLX Health
  • Kallyope
  • Vico Therapeutics
  • Faraday Pharmaceuticals
  • AgBiome
  • Metacrine
  • OM1
  • Alector
  • B2Gnow
  • Freenome
  • Mesodyne
  • Morphic Therapeutic
  • Adagio Therapeutics
  • Pandion Therapeutics
  • Montis Biosciences
  • Adimab
  • Candesant Biomedical
  • ByHeart
  • Simon Data
  • Covetrus
  • Cyclerion Therapeutics
  • KenSci
  • Neogene Therapeutics
  • Lyra Therapeutics
  • Sesh
  • Africa Healthcare Network
  • Gauss Surgical
  • EGenesis
  • Wellthy
  • Tectonic Therapeutic
  • TARIS Biomedical
  • Profitero
  • Automotive Titling Company
  • Iora Health
  • ClearSky Data
  • BlackThorn Therapeutics
  • Keeps
  • Scholar Rock
  • Dewpoint Therapeutics
  • Foresight Mental Health
  • Caledonia Spirits
  • Sonrai Security
  • Auron Therapeutics
  • Volastra Therapeutics
  • Ankyra
  • Quentis Therapeutics
  • Drizly
  • Amunix
  • Ajax Health
  • Kronos Bio
  • FidoCure
  • SQZ Biotech
  • Twistlock
  • Gossamer Bio
  • Thirty Madison
  • Dyno Therapeutics
  • Primmune Therapeutics
  • Pointy
  • Lyndra Therapeutics
  • FloQast
  • Jnana
  • SpineZone
  • Podimetrics
  • CAMP4 Therapeutics
  • IconOVir Bio
  • 1366 Technologies
  • Falkonry
  • Tausight
  • Nomad Health
  • Allstacks